There are 2949 resources available
1785P - Phase Ib expansion study of adavosertib plus olaparib in patients with extensive-stage or relapsed small cell lung cancer
Presenter: Bob Li
Session: E-Poster Display
Resources:
Abstract
1786P - Small cell lung cancer (SCLC) extensive stage (ES) in Spain: Efficacy of treatments, data from the thoracic tumours registry (TTR study)
Presenter: Enric Carcereny Costa
Session: E-Poster Display
Resources:
Abstract
1787P - Effect of anlotinib in advanced small cell lung cancer patients with pleural metastases/pleural effusion: A subgroup analysis from a randomized, double-blind phase II trial (ALTER1202)
Presenter: Ying Liu
Session: E-Poster Display
Resources:
Abstract
1789P - Fewer liver and lymph node metastases may contribute to survival benefits for patients with c-SCLC compared with SCLC
Presenter: Haiyong Wang
Session: E-Poster Display
Resources:
Abstract
1788P - Persistent sex-differences in lung cancer mortality between 2001 and 2017 in the US and EU
Presenter: Chinmay Jani
Session: E-Poster Display
Resources:
Abstract
1790P - Clinical utility of ctDNA and CTCs for genomic profiling and monitoring chemotherapy response in patients with small cell lung cancer
Presenter: Yu Feng
Session: E-Poster Display
Resources:
Abstract
1791P - Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202)
Presenter: Ying Cheng
Session: E-Poster Display
Resources:
Abstract
1792P - French real world study on patient characteristics and treatment strategies in first-line of extensive-stage small cell lung cancer (ES SCLC)
Presenter: Didier Debieuvre
Session: E-Poster Display
Resources:
Abstract
1793P - RESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC)
Presenter: Santiago Ponce
Session: E-Poster Display
Resources:
Abstract
1794P - Extensive stage (ES) small-cell lung cancer (SCLC) in Spain: A review of demographic, epidemiological and clinical data from the Thoracic Tumors Registry (TTR study)
Presenter: Virginia Calvo
Session: E-Poster Display
Resources:
Abstract